Neurologie 2007

Was ist neu?

• Schlaganfall: Vitamine zur Sekundärprävention? Frühere Ergebnisse zur Antikoagulation bestätigt. Stent oder OP bei Carotis-Stenose?

  Rehabilitation: Wissenschaft auf dem Vormarsch

  Lewy-Body-Demenz: Neues zur Therapie

  Migräne: Zusammenhang mit Myokardinfarkt?

  Bewegungsstörungen: Tiefe Hirnstimulation

  Entzündliche ZNS-Erkrankungen: differenziertere Diagnosen

Literatur

• 1 Connolly S, Pogue J. et al., ACTIVE Writing Group on behalf of the ACTIVE Investigators . Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W).  Lancet. 2006;  367 1903-1912
• 2 Bazzano L A, Reynolds K, Holder K N, He J. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials.  JAMA. 2006;  296 2720-2726
• 3 Bhatt D L, Fox K A, Hacke W. et al., CHARISMA Investigators . Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.  N Engl J Med. 2006;  354 1706-1717
• 4 Clarke R, Lewington S, Sherliker P, Armitage J. Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia.  Curr Opin Clin Nutr Metab Care. 2007;  10 32-39
• 5 Cree B A, Lamb S, Morgan K, Chen A, Waubant E, Genain C. An open label study of the effects of rituximab in neuromyelitis optica.  Neurology. 2005;  64 1270-1272
• 6 Deuschl G, Schade-Brittinger C, Krack P. et al. German Parkinson Study Group, Neurostimulation Section . A randomized trial of deep-brain stimulation for Parkinson’s disease.  N Engl J Med. 2006;  355 896-908
• 7 Diener H C, Bogousslavsky J, Brass L M. et al.; MATCH investigators . Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH).  Lancet. 2004;  364 331-337
• 8 Dietz V, Curt A. Neurological aspects of spinal-cord repair: promises and challenges.  Lancet Neurol. 2006;  5 688-694
• 9 Ekberg J, Adams D J. Neuronal voltage-gated sodium channel subtypes: key roles in inflammatory and neuropathic pain.  Int J Biochem Cell Biol. 2006;  38 2005-2010
• 10 Emre M, Aarsland D. et al . Rivastigmine for dementia associated with Parkinson’s disease.  N Engl J Med. 2004;  351 2509-2518
• 11 Halkes P H. et al., ESPRIT Study Group . Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT).  Lancet. 2006;  367 1665-1673
• 12 Greenberg B D, Malone D A, Friehs G M. et al . Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder.  Neuropsychopharmacology. 2006;  31 2384-2393
• 13 Hall G C, Carroll D, Parry D, McQuay H J. Epidemiology and treatment of neuropathic pain: the UK primary care perspective.  Pain. 2006;  122 156-162
• 14 Hummel F C, Cohen L G. Non-invasive brain stimulation: a new strategy to improve neurorehabilitation after stroke?.  Lancet Neurol. 2006;  5 708-712
• 15 Ito Y, Kurata M, Suzuki K. et al . Cardiovascular disease mortality and serum carotenoid levels.  J Epidemiol. 2006;  16 154-160
• 16 Krause P, Edrich T, Straube A. Lumbar repetitive magnetic stimulation reduces spastic tone increase of the lower limbs.  Spinal Cord. 2004;  42 67-72
• 17 Kupsch A, Benecke R. et al.; Deep-Brain Stimulation for Dystonia Study Group . Related Article. Pallidal deep-brain stimulation in primary generalized or segmental dystonia.  N Engl J Med. 2006;  355 1978-1990
• 18 Kurth T, Gaziano J M, Cook N R. et al . Migraine and risk of cardiovascular disease in women.  JAMA. 2006;  296 283-291
• 19 Kurth T, Slomke M A, Kase C S. et al . Migraine, headache, and the risk of stroke in women.  Neurology. 2005;  64 1020-1026
• 20 Lennon V A, Kryzer T J, Pittock S J. et al . IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.  J Exp Med. 2005;  202 473-477
• 21 Maidment I, Fox C, Boustani M. Cholinesterase inhibitors for Parkinson’s disease dementia.  Cochrane Database Syst Rev. 2006;  1 CD004747-n
• 22 Mas J L. et al.; EVA-3S Investigators . Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis.  N Engl J Med. 2006;  355 1660-1671
• 23 Pohl M, Werner C. et al . Repetitive locomotor training and physiotherapy improve walking and basic activities of daily living after strokel (DEutsche GAngtrainerStudie, DEGAS).  Clin Rehabil. 2007;  21 17-27
• 24 Scheidtmann K, Fries W. et al . Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study.  Lancet. 2001;  358 787-790
• 25 Schneider L S, Dagerman K, Insel P S. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.  Am J Geriatr Psychiatry. 2006;  14 191-210
• 26 Schneider L S, Tariot P N, Dagerman K S. et al.; CATIE-AD Study Group . Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s disease.  N Engl J Med. 2006;  355 1525-1538
• 27 Schwerzmann M, Nedeltchev K, Lagger F. et al . Prevalence and size of directly detected patent foramen ovale in migraine with aura.  Neurology. 2005;  65 1415-1418
• 28 Shah S, Bell R J, Davis S R. Homocysteine, estrogen and cognitive decline.  Climacteric. 2006;  9 77-87
• 29 Ringleb P A, Allenberg J, Bruckmann H. SPACE Collaborative Group . 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients.  Lancet. 2006;  368 1239-1247
• 30 The Heart Outcomees Prevention Evaluation (HOPE) 2 Investigators . Homocysteine lowering with folic acid and B vitamins in vascular disease.  N Engl J Med. 2006;  354 1567-1577
• 31 Wammes-van der Heijden E A, Tijssen C C, Egberts A C. Right-to-left shunt and migraine: the strength of the relationship.  Cephalalgia. 2006;  26 208-213
• 32 Wingerchuk D M, Weinshenker B G. Neuromyelitis Optica.  Curr Treat Options Neurol. 2005;  7 173-182